AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metjet-PG2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Medisoft Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Metjet-PG2 Tablet SR

Glycemia-Control SR is a dual-action tablet formulated to manage blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It optimizes insulin efficacy, thus reducing blood sugar. Glycemia-Control SR should be administered precisely as prescribed, including dosage and duration. Ingestion with food is recommended to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case the missed dose should be omitted. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or lactating individuals should seek medical counsel. Renal function assessment will precede treatment initiation. Limit alcohol consumption as it may exacerbate adverse effects.

Primary Ingredients of Metjet-PG2 Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Metjet-PG2 Tablet SR

Managing type 2 diabetes

Major Benefits of Metjet-PG2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metjet-PG2 Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Metjet-PG2 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Metjet-PG2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metjet-PG2 Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.

How Metjet-PG2 Tablet SR works:

Metjet-PG2 SR tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone, addressing type 2 diabetes when other treatments fall short. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Metjet-PG2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metjet-PG2 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Metjet-PG2 tablets are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Metjet-PG2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Metjet-PG2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metjet-PG2 Tablet SR cautiously, potentially requiring dosage modification under medical supervision. Metjet-PG2 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Metjet-PG2 Tablet SR :

Should you forget a Metjet-PG2 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metjet-PG2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metjet-PG2 Tablet SR

Consuming alcohol with Metjet-PG2 Tablet SR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise your risk of lactic acidosis.
Consult your doctor before taking Metjet-PG2 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you are taking, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Metformin, a component of Metjet-PG2 Tablet SR, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Metjet-PG2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a quick-sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metjet-PG2 Tablet SR
168
MRP 195
13% off